Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
McKesson
Boehringer Ingelheim
Queensland Health
Harvard Business School
Farmers Insurance
Moodys
QuintilesIMS
Dow
Cerilliant

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,211,246

« Back to Dashboard

Summary for Patent: 6,211,246
Title: Rapidly absorbed liquid compositions
Abstract:The present invention provides a method which provides for a faster absorption of pharmaceutically acceptable amines. The method provides a pharmaceutically acceptable amine in combination with a non-steroidal anti-inflammatory drug in a liquid form. A preferred embodiment employs pseudoephedrine and ibuprofen.
Inventor(s): Gelotte; Cathy Klech (North Wales, PA), Hills; Joanna F. (Glenside, PA), Pendley, II; Charles E. (Abington, PA), Shah; Manoj N. (Norristown, PA)
Assignee: McNeil-PPC, Inc. (Skillman, NJ)
Application Number:09/329,900
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;

Drugs Protected by US Patent 6,211,246

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
J And J Consumer Inc CHILDREN'S MOTRIN COLD ibuprofen; pseudoephedrine hydrochloride SUSPENSION;ORAL 021128-001 Aug 1, 2000 OTC Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 6,211,246

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,060,730 Rapidly absorbed liquid compositions ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,211,246

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Saudi Arabia 534 ➤ Subscribe
New Zealand 504944 ➤ Subscribe
South Korea 20010007332 ➤ Subscribe
Japan 2001019638 ➤ Subscribe
Spain 2397262 ➤ Subscribe
European Patent Office 1059084 ➤ Subscribe
Canada 2311039 ➤ Subscribe
Australia 3794300 ➤ Subscribe
Colombia 5160329 ➤ Subscribe
China 1151784 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
US Army
Dow
Cerilliant
Federal Trade Commission
UBS
Citi
McKinsey
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot